Idalopirdine for Alzheimer's disease: Written in the stars

The Lancet Neurology

Volumn 13, Issue 11, 2014, Pages 1063-1065

  Schneider, Lon S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 PHENYLSULFONYL 8 (1 PIPERAZINYL)QUINOLINE; DONEPEZIL; IDALOPIRDINE; SEROTONIN 6 RECEPTOR; (2-(6-FLUORO-1H-INDOL-3-YL)-ETHYL)-(3-(2,2,3,3-TETRAFLUOROPROPOXY)BENZYL)AMINE; BENZYLAMINE DERIVATIVE; INDOLE DERIVATIVE; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ALZHEIMER DISEASE; AUSTRALIA; BRAIN CORTEX; CANADA; COGNITION; DAILY LIFE ACTIVITY; DISEASE SEVERITY; EUROPE; HISTOPATHOLOGY; HUMAN; NEUROPSYCHOLOGICAL TEST; NEUROTRANSMISSION; NOTE; NUCLEUS ACCUMBENS; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); UNCERTAINTY; FEMALE; MALE;

ALZHEIMER DISEASE; BENZYLAMINES; FEMALE; HUMANS; INDOLES; MALE; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 84907965476     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(14)70232-7     Document Type: Note

References (12)

1. Becker RE, Greig NH, Giacobini E Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?. J Alzheimers Dis 2008, 15:303-325.
2. 6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol 2014, published online Oct 6. http://dx.doi.org/10.1016/S1474-4422(14)70198-X.
3. 6 receptor antagonists as novel cognitive enhancing agents for Alzheimer's disease. Neurotherapeutics 2008, 5:458-469.
4. 6 antagonist SB-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate. Br J Pharmacol 2000, 130:23-26.
5. 6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology 2001, 25:662-668.
6. 6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats. Int J Neuropsychopharmacol 2010, 13:1021-1033.
7. de Bruin NMWJ, Prickaerts J, van Loevezijn A, et al. Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats. Neurobiol Learn Mem 2011, 96:392-402.
8. 6 receptor antagonist, SB-742457, in Alzheimers disease. Curr Alzheimer Res 2010, 7:374-385.
9. Maher-Edwards G, Dixon R, Hunter J, et al. SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study. Int J Geriatr Psychiatry 2011, 26:536-544.
10. Schaffhauser H, Mathiasen JR, DiCamillo A, et al. Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities. Biochem Pharmacol 2009, 78:1035-1042.
11. Jones R Dimebon disappointment. Alzheimers Res Ther 2010, 2:25.
12. Schneider LS, Insel PS, Weiner MW Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative. Arch Neurol 2011, 68:58-66. for the Alzheimer's Disease Neuroimaging Initiative.